ImageneBio Share Price
NASDAQ: IMA | Micro Cap | Healthcare$4.10
+$4.10 (--%) Last updated on 20 Nov, 2026 | 02:19 ISTImageneBio Stock Performance
ImageneBio Share Price Chart
$0.00$0.00
L
H
ImageneBio Quarterly Profit & Loss
All figures in USD
ImageneBio Annual Profit & Loss
All figures in USD
ImageneBio Balance Sheet
All figures in USD Million
ImageneBio Cash Flow
Annually
All figures in USD Million
About ImageneBio
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
ImageneBio Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $4.05 | $3.92 | -4.51% |
Oct 2026 | $4.58 | $4.10 | -17.09% |
Sep 2026 | $4.96 | $4.95 | -10.50% |
Aug 2026 | $5.33 | $5.53 | -3.07% |
Jul 2026 | $5.81 | $5.70 | -6.25% |
Jun 2026 | $5.56 | $6.08 | +3.40% |
May 2026 | $5.89 | $5.88 | -2.81% |
Apr 2026 | $4.96 | $6.05 | +26.30% |
Mar 2026 | $6.24 | $4.79 | -31.47% |
Feb 2026 | $7.23 | $6.99 | -6.68% |
Jan 2026 | $6.87 | $7.49 | +9.02% |
Dec 2025 | $6.71 | $6.87 | -3.24% |